The research team is now monitoring 12 more participants who received higher doses of 150,000 and 250,000 cells. If no safety ...

A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show ...

In a study published in Cell Stem Cell, scientists tested retinal pigment epithelial stem cells in a phase 1/2a clinical trial. The cells were obtained from adult postmortem eye tissue. These ...

Living in a world with limited sight can cause some serious misunderstanding. Spend 59 seconds with Pete to hear about this ...

Valitor, a biotechnology company engineering a new generation of ophthalmic medicines, today announced its chief executive officer, Gregory D. Kunst, will present preclinical data highlighting the ...

The clinical trial enrolled 38 adults aged 60 and older who had advanced geographic atrophy, the late stage of macular ...

The actresses teamed up to appear in an advert for ShelterBox, a disaster relief charity that provides essential items to ...

Mark Wetzel's ability to teach the art of hitting is a sight to behold, but the real masterclass is his outlook on facing life's curveballs.

Q3 2025 Earnings Call November 17, 2025 8:30 AM ESTCompany ParticipantsMatthew Duffy - Chief Business Officer & ...

Detailed price information for Kalaris Therapeutics Inc (KLRS-Q) from The Globe and Mail including charting and trades.

Editing a gene known to increase risk of Alzheimer’s with a gene associated with lower risk shows promise for treating the ...

Looking back at 2017, it’s clear that a lot of cool new technology inventions came out. Some of them were pretty wild, others ...